Product Images Zanaflex

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Zanaflex NDC 70515-594 by Covis Pharma Us, Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structural Formula - image 01

Structural Formula - image 01

Figure 1 - image 02

Figure 1 - image 02

Figure 2 - image 03

Figure 2 - image 03

This appears to be a graph showing the improvement in Ashworth Score as a function of time post-dose for two different doses (8mg and 16mg) of tizanidine. The x-axis shows the hours post-dose, and the y-axis shows the Ashworth Score, which is a measure of spasticity in patients with neurological conditions. However, without knowing more about the context in which this graph appears, it is difficult to provide more information.*

Figure 3 - image 04

Figure 3 - image 04

This text suggests that there was an improvement in Ashworth Score after taking Tizanidine. The mean dose was 26.8 mg. The rest of the text is not clear or readable.*

Principal Display Panel - 2 mg Capsule Bottle - image 05

Principal Display Panel - 2 mg Capsule Bottle - image 05

Each capsule contains 229 mg of tizanidine hydrochloride, equivalent to 2mg of tizanidine base. Manufactured by Covis Pharma in Switzerland, Zanaflex Capsules ® comes in 150 capsules. It is recommended to store it at a temperature between 15-30°C or a USP Controlled Room Temperature, and to dispense in containers with child-resistant closure. Keep it out of the reach of children. No prescribing information provided.*

Principal Display Panel - 4 mg Capsule Bottle - image 06

Principal Display Panel - 4 mg Capsule Bottle - image 06

Zanaflex is a medication that contains tizanidine hydrochloride. Each capsule has 4.58mg of tizanidine hydrochloride equivalent to 4 mg of tizanidine base. It is manufactured by CovisPharma and comes in a container of 150 capsules. The medication should be stored at room temperature and out of reach of children. Prescribing information can be found in the package insert. The product has a GTIN number of 0037051560415.*

Principal Display Panel - 6 mg Capsule Bottle - image 07

Principal Display Panel - 6 mg Capsule Bottle - image 07

Each capsule contains 6.87 mg tizanidine hydrochloride, equivalent to mg tizanidine base. Manufactured by Covis Pharma in Zug, Switzerland. Zanaflex Capsules come in a 150 count bottle and include prescribing information in the package insert. Store at room temperature and keep in containers with child-resistant closures. The lot number and expiration date are printed on the packaging. Keep out of reach of children.*

Principal Display Panel - 4 mg Tablet Bottle - image 08

Principal Display Panel - 4 mg Tablet Bottle - image 08

This is a description of a medication called Tizanidine Hydrochloride, which comes in tablet form. Each tablet contains 4576 grams of tizanidine HCI (tizanidine base). The medication is packaged in a bottle of 150 tablets and has an NDC number of 70515. There isn't any information on what the medication is used for or any dosage instructions.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.